Neola Medical Valuation

Is NEOLA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NEOLA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate NEOLA's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate NEOLA's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NEOLA?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for NEOLA. This is calculated by dividing NEOLA's market cap by their current preferred multiple.
What is NEOLA's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	SEK 158.54m

NEOLA key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	11.7x
Enterprise Value/EBITDA	-14.7x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does NEOLA's PS Ratio compare to its peers?

The above table shows the PS ratio for NEOLA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	4.4x
NOSA Nosa Plugs	11.9x	38.7%	SEK 138.7m
ARCOMA Arcoma	0.9x	8.3%	SEK 150.3m
GTAB B Glycorex Transplantation	3.4x	n/a	SEK 106.3m
SDOS ScandiDos	1.5x	n/a	SEK 94.6m
NEOLA Neola Medical	13.3x	36.5%	SEK 158.5m

Price-To-Sales vs Peers: NEOLA is expensive based on its Price-To-Sales Ratio (13.3x) compared to the peer average (4.4x).

Price to Earnings Ratio vs Industry

How does NEOLA's PE Ratio compare vs other companies in the SE Medical Equipment Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	33.0%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	33.0%
	n/a	n/a	n/a

No more companies

Price-To-Sales vs Industry: NEOLA is expensive based on its Price-To-Sales Ratio (13.3x) compared to the Swedish Medical Equipment industry average (4.6x).

Price to Sales Ratio vs Fair Ratio

What is NEOLA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NEOLA PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	13.3x
Fair PS Ratio	8.2x

Price-To-Sales vs Fair Ratio: NEOLA is expensive based on its Price-To-Sales Ratio (13.3x) compared to the estimated Fair Price-To-Sales Ratio (8.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.